Bank of America
DBTX

Bank of America’s Decibel Therapeutics, Inc. Common Stock DBTX Stock Holding History

Bank of America’s Portfolio DBTX Stock Details DBTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-750
Closed -$2.27K – 8077
2023
Q1 		$2.27K Sell
750
-40
-5% -$138 ﹤0.01% 7200
2022
Q4 		$1.62K Sell
790
-4,474
-85% -$13.6K ﹤0.01% 7269
2022
Q3 		$19K Sell
5,264
-5,683
-52% -$25.9K ﹤0.01% 7068
2022
Q2 		$46K Sell
10,947
-7,742
-41% -$18.3K ﹤0.01% 6875
2022
Q1 		$56K Buy
18,689
+4,966
+36% +$19K ﹤0.01% 7134
2021
Q4 		$64K Sell
13,723
-5,550
-29% -$38.2K ﹤0.01% 7094
2021
Q3 		$148K Buy
19,273
+18,081
+1,517% +$138K ﹤0.01% 6497
2021
Q2 		$10K Sell
1,192
-5,661
-83% -$49.9K ﹤0.01% 7300
2021
Q1 		$78K Buy
+6,853
New +$108K ﹤0.01% 6490

Other funds holding DBTX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
HMC
Harvard Management Company Boston, Massachusetts $1.82B AUM 26.23% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Bank of America's DBTX Position: Q2 2023 in Review

Bank of America sold out of Decibel Therapeutics, Inc. Common Stock (DBTX) in Q2 2023, closing a stake of 750 shares — an estimated $2.27K sold.

Bank of America first reported a position in DBTX in Q1 2021 and held it in 9 quarters. The position peaked at $148K in Q3 2021. 37 funds tracked by Wall St. Rank hold DBTX as of Q2 2023.

  • Bank of America reported no remaining Decibel Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Bank of America sold 750 Decibel Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $2.27K.
  • Bank of America first reported a position in Decibel Therapeutics, Inc. Common Stock in Q1 2021 and held it in 9 quarters.
  • Bank of America's Decibel Therapeutics, Inc. Common Stock position peaked at $148K in Q3 2021.
  • 37 funds tracked by Wall St. Rank held Decibel Therapeutics, Inc. Common Stock as of Q2 2023.

Based on Bank of America's 13F filing for Q2 2023, filed 14 Aug 2023.